<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02605187</url>
  </required_header>
  <id_info>
    <org_study_id>34740</org_study_id>
    <nct_id>NCT02605187</nct_id>
  </id_info>
  <brief_title>Patient-Driven Analgesic Protocol Selection for Post-Cesarean Pain Management</brief_title>
  <official_title>Patient-Driven Analgesic Protocol Selection for Post-Cesarean Pain Management</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The ability to predict pain and then apply modified treatment protocols has been limited.
      Current practice is for physicians to select standard post-operative pain treatment protocols
      without patient consultation. This study hopes to determine if patient's involvement in
      analgesic drug/dosage selection can optimize pain relief while minimizing related side
      effects. This could result in a more patient-centered care model and individualized
      perioperative analgesic treatment protocols based on patient's preferences, needs and
      expectations.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This randomized, controlled study will include a simple, preoperative questionnaire to obtain
      baseline demographic and obstetric data; and complete questions (that have previously been
      shown to be predictive of postoperative pain) from which we will determine their expected and
      target postoperative pain scores. These questionnaires should take less than 3-4 minutes to
      complete.

      The subject will then be randomized into &quot;choice&quot; and &quot;no choice&quot; groups. The randomization
      for choice vs. no choice will be at a 1:3 ratio i.e. 1 woman will get no choice and 3 will
      get a choice for their analgesic protocol. All women will receive the same medications for
      intraoperative anesthetic management -- only the postoperative pain medications will be
      altered.

      The no choice group will receive the current standard analgesic protocol: medium dose
      intrathecal morphine, and around the clock acetaminophen po q6h and ibuprofen po q6h.

      The group with the choice will be offered 3 different protocols:

      1. low dose intrathecal morphine, and around the clock acetaminophen po q6h and ibuprofen po
      q6h. 2 medium dose intrathecal morphine, and around the clock acetaminophen po q6h and
      ibuprofen po q6h. 3. high dose intrathecal morphine, and around the clock acetaminophen po
      q6h and ibuprofen po q6h, as well as gabapentin po one time within 1 hr of delivery.

      Women randomized to the &quot;choice&quot; group will select a protocol after being given a standard
      script explaining advantages and disadvantages of each protocol.

      Drugs and doses utilized in the study are safe for postpartum women and within dose range
      routinely used at our and other institutions.

      All breakthrough pain will be managed the same for all patients, and adequate analgesia will
      be available to treat post-operative pain.

      Primary breakthrough rescue analgesic will be our standard oral opioid oxycodone managed
      using our current treatment algorithm. If pain 1-4 out of 10, 1 tablet (5 mg) will be
      offered, if pain &gt;4 out of 10, 2 tablets (10 mg) will be offered PRN. Pain not responding to
      oral opioids will be offered IV morphine boluses or PCA as per standard treatment protocols.
      Additional analgesic options (e.g. TAP blocks) will also be available as per standard care.

      Following standard Cesarean delivery, postoperative data will be collected (directly from
      patients and from the electronic medical record) by study investigators blinded to group
      assignment.

      Outcome measures:

        1. Pain scores at rest and on to sitting (VPS 0-10) collected at 3, 6, 12, 24, 36, 48 hours
           post-cesarean

        2. Overall daily pain score and its deviation from target and expected pain score will be
           determined at 0-24 and &gt;24-48 hours study periods.

        3. Opioid use (oral and IV morphine) in the 0-24 and &gt;24-48 hour study periods.

        4. Time to first analgesic for breakthrough pain (minutes from spinal)

        5. Side effect: Pruritus score (0-100), nausea score (0-100) and number of episodes of
           vomiting for the 0-24 and &gt;24-48 hour post- operative periods

        6. Any treatment of pruritus and/or nausea/vomiting

        7. Satisfaction with postoperative analgesia score (0-100)

        8. Discharge time (hours/minutes from surgery end)

      Telephone follow-up for pain score, opioid use, and functional recovery will be performed at
      1 week, 1 month, 3 months and 6 months post-Cesarean. The telephonic questions will last 3-4
      minutes
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 2015</start_date>
  <completion_date type="Actual">May 22, 2017</completion_date>
  <primary_completion_date type="Actual">May 22, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain scores AUC</measure>
    <time_frame>48 hours</time_frame>
    <description>Pain scores at rest and on to sitting (VPS 0-10) post-cesarean</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Opioid use</measure>
    <time_frame>48 hours postop.</time_frame>
    <description>Opioid use in the first 48hours in mg-morphine equivalents</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Presence of pruritus</measure>
    <time_frame>48 hours</time_frame>
    <description>Number of participants with pruritus during first 48hours</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment of pruritus</measure>
    <time_frame>48 hours</time_frame>
    <description>Medical treatment of pruritus during first 48hours</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence of nausea</measure>
    <time_frame>48 hours</time_frame>
    <description>Number of participants with nausea during first 48 hours</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nausea</measure>
    <time_frame>48 hours</time_frame>
    <description>Medical treatment of nausea during first 48hours</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Discharge time</measure>
    <time_frame>Through discharge, an average of 4 days</time_frame>
    <description>hours/minutes from surgery end until discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Deviation from target pain score</measure>
    <time_frame>0-48 hours</time_frame>
    <description>Difference between overall daily pain score and patient's target pain score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to breakthrough pain</measure>
    <time_frame>0-48 hours</time_frame>
    <description>Time from spinal dose to first analgesic for breakthrough pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction</measure>
    <time_frame>0-48 hours</time_frame>
    <description>Satisfaction with postop analgesia score 0-100</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">160</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>No choice</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>No choice given medium dose intrathecal morphine acetaminophen po q6h ibuprofen po q6h</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Choice: low protocol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Choice given low dose intrathecal morphine acetaminophen po q6h ibuprofen po q6h</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Choice: medium protocol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Choice given medium dose intrathecal morphine acetaminophen po q6h ibuprofen po q6h</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Choice: high protocol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Choice given high dose intrathecal morphine acetaminophen po q6h ibuprofen po q6h gabapentin po one time dose</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No choice given</intervention_name>
    <description>Patients are randomized to getting a choice or not getting a choice. If they do not get a choice, they receive standard dose.</description>
    <arm_group_label>No choice</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Choice given</intervention_name>
    <description>Patients are randomized to getting a choice or not getting a choice. If they do get a choice, they will receive the protocol they select.</description>
    <arm_group_label>Choice: low protocol</arm_group_label>
    <arm_group_label>Choice: medium protocol</arm_group_label>
    <arm_group_label>Choice: high protocol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ibuprofen</intervention_name>
    <description>Ibuprofen 600mg po q6h</description>
    <arm_group_label>No choice</arm_group_label>
    <arm_group_label>Choice: low protocol</arm_group_label>
    <arm_group_label>Choice: medium protocol</arm_group_label>
    <arm_group_label>Choice: high protocol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetaminophen</intervention_name>
    <description>Acetaminophen 650mg po q6h</description>
    <arm_group_label>No choice</arm_group_label>
    <arm_group_label>Choice: low protocol</arm_group_label>
    <arm_group_label>Choice: medium protocol</arm_group_label>
    <arm_group_label>Choice: high protocol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Gabapentin</intervention_name>
    <description>Gabapentin 600mg po one time within 1 hour of delivery</description>
    <arm_group_label>Choice: high protocol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine (low)</intervention_name>
    <description>Intrathecal morphine dose 50mcg</description>
    <arm_group_label>Choice: low protocol</arm_group_label>
    <other_name>Low dose morphine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine (med)</intervention_name>
    <description>Intrathecal morphine dose 150mcg</description>
    <arm_group_label>No choice</arm_group_label>
    <arm_group_label>Choice: medium protocol</arm_group_label>
    <other_name>Medium dose morphine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine (high)</intervention_name>
    <description>Intrathecal morphine 300mcg</description>
    <arm_group_label>Choice: high protocol</arm_group_label>
    <other_name>High dose morphine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women age 18-50

          -  Singleton gestation

          -  Not in active labor

          -  Scheduled for their 1st, 2nd, or 3rd elective Cesarean

          -  Cesarean deliveries under spinal or combined spinal epidural anesthesia (with no
             additional epidural doses administered)

        Exclusion Criteria:

          -  History of chronic pain, anxiety, or depression

          -  Unable to understand the concept of Verbal Numerical Pain Scale at the time of
             informed consent

          -  Chronic consumption of opiates, antidepressants or anticonvulsants

          -  Intake of opioids, NSAIDS or acetaminophen 48hrs prior to the psychophysical test

          -  Preeclampsia (with any severe features)

          -  Diabetes (not controlled with diet and needing drugs)

          -  Preterm delivery (&lt;35 weeks gestation)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brendan Carvalho, MBBCh, MDCH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Lucille Packard Children's Hospital</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Eisenach JC, Pan P, Smiley RM, Lavand'homme P, Landau R, Houle TT. Resolution of pain after childbirth. Anesthesiology. 2013 Jan;118(1):143-51. doi: 10.1097/ALN.0b013e318278ccfd.</citation>
    <PMID>23249931</PMID>
  </reference>
  <reference>
    <citation>Eisenach JC, Pan PH, Smiley R, Lavand'homme P, Landau R, Houle TT. Severity of acute pain after childbirth, but not type of delivery, predicts persistent pain and postpartum depression. Pain. 2008 Nov 15;140(1):87-94. doi: 10.1016/j.pain.2008.07.011. Epub 2008 Sep 24.</citation>
    <PMID>18818022</PMID>
  </reference>
  <reference>
    <citation>Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet. 2006 May 13;367(9522):1618-25. Review.</citation>
    <PMID>16698416</PMID>
  </reference>
  <reference>
    <citation>Lavand'homme P. Perioperative pain. Curr Opin Anaesthesiol. 2006 Oct;19(5):556-61. Review.</citation>
    <PMID>16960491</PMID>
  </reference>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 10, 2015</study_first_submitted>
  <study_first_submitted_qc>November 12, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 16, 2015</study_first_posted>
  <last_update_submitted>October 3, 2017</last_update_submitted>
  <last_update_submitted_qc>October 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Brendan Carvalho</investigator_full_name>
    <investigator_title>Chief, Division of Obstetric Anesthesia Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine</investigator_title>
  </responsible_party>
  <keyword>cesarean</keyword>
  <keyword>postoperative pain</keyword>
  <keyword>patient choice</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Ibuprofen</mesh_term>
    <mesh_term>Analgesics</mesh_term>
    <mesh_term>Gabapentin</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>April 20, 2018</submitted>
    <submission_canceled>Unknown</submission_canceled>
    <submitted>May 9, 2018</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

